Andreas Voss is the Vice President of Medical and Clinical Affairs for Caris Life Sciences® in Europe. Prior to joining Caris he was responsible for the global clinical development of Avastin, and a member of the Corporate Drug Safety Board at F. Hoffmann- La Roche in Basel. Before joining Roche, Andreas held various positions in early and late development and marketing in global pharmaceutical companies. Andreas gained his medical degree at the University of Hamburg and was a postdoctoral fellow at the University of California at San Diego. He is board certified in internal medicine.